UAE BARQ برق الإمارات – نبضك
The UAE Ministry of Health and Prevention, in collaboration with Department of Health – Abu Dhabi and Dubai Health Authority, has announced the effectiveness of Covid 19 medicine Sotrovimab in treating mild to moderate cases among high risk-patients.
Between 30 June and 13 July, 6,175 patients received Sotrovimab, leading to 97 per cent of recipients fully recovering within 14 days, 100 per cent prevention of death, and 99 per cent prevention of admission to ICU.
About 52 per cent were aged 50 or above and almost all recipients had multiple comorbidities including obesity, cancer, cardiovascular disease and diabetes.
